Tag: $Zealand Pharma A/S

Weight loss drug contender Zealand Pharma jumps 23% on trial results

Shares of Denmark’s Zealand Pharma popped nearly 23% in Friday morning deals, notching a record high after an early-stage study of its weight loss drug challenger produced positive results.

Novo Nordisk and Eli Lilly rival soars 32% after promising weight-loss drug results

Shares of Denmark’s Zealand Pharma shot 32% higher in morning trade, after results showed success in its liver disease treatment survodutide, which is also on trial as a drug to treat obesity.